The arrival of Retatrutide ZPHC, at a strength of 120mg, is creating considerable excitement within the weight loss community. This innovative dual GIP and GLP-1 receptor medication appears to offer impressive improvements in body reduction compared to existing therapies. Initial patient data have demonstrated marked reductions in body mass , possi